Clinical trial
Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment…
NCT00150605 · Validus Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00150605 |
|---|---|
| Title | Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder |
| Official title | A Phase IIIb, Open Label Observational Study of SPD417 Used in Combination With Other Psychotropic Medications for the Treatment of Bipolar I Disorder |
| Lead sponsor | Validus Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Extended-release carbamazepine |
| Enrollment | 50 |
| Start date | Feb 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | Nov 2, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: